Role of nitric oxide in tumour progression: lessons from human tumours.

作者: Lindy L. Thomsen , David W. Miles

DOI: 10.1023/A:1005912906436

关键词:

摘要: Varied cellular expression and localisation of nitric oxide synthase (NOS) isoforms has been shown in human cancers, including tumours the breast, ovary, stomach, cervix central nervous system. Mapping NOS within tumour tissue from breast gastric cancers shows inducible (iNOS) is expressed predominantly stromal (macrophage endothelial) cells, although level activity at least 1-2 orders magnitude lower than enzyme associated with cytotoxicity apoptosis. There evidence that intratumoural environment may provide chemoattractant signals for monocyte-macrophage recruitment their subsequent activation via interleukin-4, IgE, CD23. Such lead to induction iNOS macrophages vitro. The correlation between grade cancer suggests NO a positive growth signal microenvironment. In vivo studies showing increased rate, vascular density invasiveness cell line transfected constitutively express support this. Furthermore, administration highly selective inhibitor limited invasion rate other murine expressing this isoform. Inhibition generation microenvironment prove useful therapy by preventing angiogenesis, metastasis.

参考文章(55)
Marek W Radomski, David C Jenkins, Lesley Holmes, Salvador Moncada, None, Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Research. ,vol. 51, pp. 6073- 6078 ,(1991)
James Adams, Isaiah J. Fidler, Robert G. Kilbourn, Limin Li, Role of Nitric Oxide in Lysis of Tumor Cells by Cytokine-activated Endothelial Cells Cancer Research. ,vol. 51, pp. 2531- 2535 ,(1991)
Robert Keller, Ruth Keist, Michael Geiges, l-Arginine-dependent Reactive Nitrogen Intermediates as Mediators of Tumor Cell Killing by Activated Macrophages Cancer Research. ,vol. 50, pp. 1421- 1425 ,(1990)
Garth L. Nicolson, Isaiah J. Fidler, Limin Li, Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Research. ,vol. 51, pp. 245- 254 ,(1991)
R G Knowles, S Moncada, Nitric oxide synthases in mammals. Biochemical Journal. ,vol. 298, pp. 249- 258 ,(1994) , 10.1042/BJ2980249
Kenneth D. Aldape, Jay E. Brenman, David S. Bredt, Mark A. Israel, Charles S. Cobbs, Expression of nitric oxide synthase in human central nervous system tumors. Cancer Research. ,vol. 55, pp. 727- 730 ,(1995)
P P Rosen, S Groshen, P E Saigo, D W Kinne, S Hellman, Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. Journal of Clinical Oncology. ,vol. 7, pp. 1239- 1251 ,(1989) , 10.1200/JCO.1989.7.9.1239
J Wagstaff, L L Thomsen, E M Rankin, A C Ogilvie, G J van Mierlo, A J Erenberg, C E Hack, K Hoekman, IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer. Journal of Immunology. ,vol. 156, pp. 389- 394 ,(1996)
R M Palmer, S Moncada, E A Higgs, NITRIC OXIDE: PHYSIOLOGY, PATHOPHYSIOLOGY, AND PHARMACOLOGY Pharmacological Reviews. ,vol. 43, pp. 109- 142 ,(1991)
G Werner-Felmayer, E R Werner, D Fuchs, A Hausen, B Mayer, G Reibnegger, G Weiss, H Wachter, Ca2+/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Biochemical Journal. ,vol. 289, pp. 357- 361 ,(1993) , 10.1042/BJ2890357